DR. HENDRIK ROSIES
0837.902.232 · rovalta.com · 26/09/2026
DR. HENDRIK ROSIES
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODR. HENDRIK ROSIES is a Private limited company incorporated in 2011. Its main activity is: General medical practice activities. Its registered office is in Leuven.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0837.902.232
- Incorporation
- 14/07/2011
- Legal form
- Private limited company
- Registered office
- Vinkenbosstraat 3
3001 Leuven · FlandreSee on map - Contributed capital
- 12 500,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 14 filingsTrend over 14 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 402,2 k € | +12.5% | 357,4 k € | +12.7% | 317,2 k € | -5.3% | 335 k € | -16.0% | 398,8 k € |
| EBITDA | 392 k € | +15.0% | 340,8 k € | +10.0% | 309,9 k € | -5.4% | 327,7 k € | -15.1% | 386,1 k € |
| Operating result | 318,4 k € | +21.2% | 262,7 k € | +16.6% | 225,3 k € | -11.3% | 253,9 k € | -20.8% | 320,7 k € |
| Net result | 244,4 k € | +29.4% | 188,9 k € | +15.4% | 163,6 k € | -15.7% | 194,1 k € | -17.7% | 235,9 k € |
| Balance sheet | |||||||||
| Equity | 472,5 k € | +53.3% | 308,1 k € | +26.2% | 244,2 k € | +1.5% | 240,6 k € | +1.7% | 236,5 k € |
| Total assets | 1,1 M € | +3.3% | 1,1 M € | -5.8% | 1,2 M € | -6.0% | 1,2 M € | -6.9% | 1,3 M € |
| Cash | 69,5 k € | -22.4% | 89,6 k € | +238% | 26,5 k € | -20.9% | 33,5 k € | -17.4% | 40,6 k € |
| Debts | 656,6 k € | -16.3% | 784,6 k € | -14.3% | 915,8 k € | -7.8% | 993,1 k € | -8.8% | 1,1 M € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 2 ended
Active mandates
Ended mandates
Other companies at this address
Vinkenbosstraat 3 3001 Leuven| Company | CBE no. |
|---|---|
Dragons Athletics● Active | 1014.165.088 |
Dragons Cheer Athletics● Active | 0801.851.587 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 21/09/2026 | 27/08/2025 | 30/08/2024 | 30/08/2023 | 29/07/2022 | 29/10/2021 |
| General meeting | 22/05/2026 | 23/05/2025 | 24/05/2024 | 26/05/2023 | 27/05/2022 | 30/07/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 22/05/2026 | 21/09/2026 | Dutch | |
| Micro model | 31/12/2024 | 23/05/2025 | 27/08/2025 | Dutch | |
| Micro model | 31/12/2023 | 24/05/2024 | 30/08/2024 | Dutch | |
| Micro model | 31/12/2022 | 26/05/2023 | 30/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 27/05/2022 | 29/07/2022 | Dutch | |
| Micro model | 31/12/2020 | 30/07/2021 | 29/10/2021 | Dutch | |
| Micro model | 31/12/2019 | 30/06/2020 | 31/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 30/06/2019 | 31/07/2019 | Dutch | |
| Micro model | 31/12/2017 | 30/06/2018 | 01/08/2018 | Dutch | |
| Micro model | 31/12/2016 | 30/06/2017 | 31/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 30/06/2016 | 28/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 30/06/2015 | 29/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 23/06/2014 | 01/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 24/06/2013 | 23/07/2013 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 2 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025244,4 k €↑
- 2024Annual accounts 2024188,9 k €↑
- 2023Annual accounts 2023163,6 k €↓
- 2023Name changeDr. Hendrik Rosies
- 2022Annual accounts 2022194,1 k €↓
- 2021Annual accounts 2021235,9 k €↑
- 2021Name changeHENDRIK ROSIES DOKTER
- 2020Annual accounts 2020127,2 k €↓
- 2019Annual accounts 2019138,8 k €↑
- 2018Annual accounts 201852,9 k €↓
- 2017Annual accounts 201764,5 k €↓
- 2016Annual accounts 201689,9 k €↑
- 2015Annual accounts 201582,1 k €↑
- 2014Annual accounts 201429,7 k €↓
- 2013Annual accounts 201353,3 k €↑
- 2012Annual accounts 201246,3 k €
- 14/07/2011IncorporationPrivate limited company